Anal Precancerous Condition clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
Sorry, in progress, not accepting new patients
This is a phase II double blind, placebo-controlled, randomized study of Artesunate suppositories for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)
San Francisco, California and other locations
Our lead scientists for Anal Precancerous Condition research studies include Joel Palefsky, MD.
Last updated: